Marksans Pharma Ltd

marksanspharma.com BSE: 524404 NSE : MARKSANS
About [ edit ]

Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products.

Our key focus areas lie in the OTC & prescription drugs that have wide-ranging applications across fields like Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, Gynaecology, among others. #

Key Points [ edit ]
Website BSE NSE
  • Market Cap ₹ 2,851 Cr.
  • Current Price ₹ 69.6
  • High / Low ₹ 70.0 / 18.0
  • Stock P/E 14.1
  • Book Value ₹ 18.0
  • Dividend Yield 0.14 %
  • ROCE 25.6 %
  • ROE 19.9 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • The company has delivered a poor sales growth of 7.32% over past five years.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
199 235 269 248 247 245 256 288 335 331 356 358
195 200 232 212 232 213 223 240 266 261 273 267
Operating Profit 4 35 37 36 16 32 34 47 69 70 83 91
OPM % 2% 15% 14% 15% 6% 13% 13% 16% 21% 21% 23% 25%
Other Income 0 3 -1 0 10 2 8 0 0 0 4 -3
Interest 3 2 3 2 2 2 3 2 2 2 2 2
Depreciation 6 6 6 5 6 5 5 7 10 7 19 9
Profit before tax -6 30 28 30 17 28 34 38 58 61 66 78
Tax % -14% 18% 26% 15% 41% 19% 23% 23% 26% 20% 23% 24%
Net Profit -6 25 21 25 10 22 26 30 43 49 51 59
EPS in Rs -0.16 0.61 0.50 0.61 0.24 0.55 0.63 0.72 1.04 1.21 1.24 1.44
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
356 359 305 356 438 630 797 893 767 913 1,000 1,134 1,381
334 336 378 455 369 512 612 757 722 834 868 942 1,068
Operating Profit 22 24 -73 -100 69 118 185 136 45 78 132 192 313
OPM % 6% 7% -24% -28% 16% 19% 23% 15% 6% 9% 13% 17% 23%
Other Income 8 2 -78 2 4 4 3 9 7 8 5 0 1
Interest 21 19 44 54 15 19 16 10 7 10 10 9 7
Depreciation 15 15 20 24 16 16 16 28 30 27 23 27 44
Profit before tax -7 -9 -215 -175 44 86 156 107 15 50 104 157 262
Tax % -14% -4% -3% -1% -12% 15% 28% 23% 24% 28% 23% 23%
Net Profit -8 -10 -223 -179 46 72 109 79 9 33 76 117 202
EPS in Rs 1.19 1.87 2.67 1.92 0.22 0.80 1.87 2.86 4.93
Dividend Payout % -7% 0% 0% -0% 10% 5% 4% 21% 23% 6% 3% 4%
Compounded Sales Growth
10 Years:12%
5 Years:7%
3 Years:14%
TTM:33%
Compounded Profit Growth
10 Years:30%
5 Years:1%
3 Years:137%
TTM:130%
Stock Price CAGR
10 Years:38%
5 Years:8%
3 Years:28%
1 Year:242%
Return on Equity
10 Years:%
5 Years:13%
3 Years:15%
Last Year:20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions
Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
50 50 50 50 52 52 53 53 41 41 41 41 41
Reserves 100 111 -115 -220 34 90 326 401 392 430 502 595 698
Borrowings 397 424 135 179 163 160 89 88 110 118 100 19 22
108 86 436 389 165 202 220 192 209 142 160 241 293
Total Liabilities 642 658 492 385 401 490 676 722 752 731 802 896 1,054
380 392 279 165 156 146 166 270 267 279 270 303 303
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 10 0 0 0 0 0 0 0 0 0 0 0
261 256 213 220 245 344 510 452 484 451 533 593 751
Total Assets 642 658 492 385 401 490 676 722 752 731 802 896 1,054

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
20 17 -65 -62 39 65 155 31 14 50 27 210
-118 -35 25 -3 -5 -4 -33 -123 -21 -39 -13 -60
59 32 36 57 -40 -29 17 -58 -3 3 -21 -90
Net Cash Flow -39 13 -5 -9 -7 31 138 -150 -10 15 -7 60

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 3% 2% -28% -306% 45% 38% 45% 23% 4% 11% 19% 26%
Debtor Days 104 96 118 116 109 98 84 89 118 71 64 78
Inventory Turnover 1.93 2.35 1.42 3.10 3.43 4.17 3.91 3.51 2.64 2.62 2.00 2.09

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25 48.25
4.30 4.09 3.59 3.45 3.18 2.46 2.44 2.54 3.28 4.69 5.05 4.34
0.34 0.47 0.50 0.62 0.51 0.66 0.64 0.89 0.67 0.30 0.30 0.34
47.11 47.19 47.66 47.68 48.06 48.64 48.67 48.32 47.80 46.76 46.40 47.07

Documents

Recent announcements


View all

Annual reports

Credit ratings

Concalls